Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
DT2216
i
Other names:
DT2216
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Dialectic Therap
Drug class:
Bcl-xL degrader
‹
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
KRAS G12C
Colorectal Cancer
KRAS G12C
Colorectal Cancer
sotorasib + DT2216
Sensitive: D – Preclinical
sotorasib + DT2216
Sensitive
:
D
sotorasib + DT2216
Sensitive: D – Preclinical
sotorasib + DT2216
Sensitive
:
D
KRAS G12C
Non Small Cell Lung Cancer
KRAS G12C
Non Small Cell Lung Cancer
sotorasib + DT2216
Sensitive: D – Preclinical
sotorasib + DT2216
Sensitive
:
D
sotorasib + DT2216
Sensitive: D – Preclinical
sotorasib + DT2216
Sensitive
:
D
KRAS G12C
Pancreatic Cancer
KRAS G12C
Pancreatic Cancer
sotorasib + DT2216
Sensitive: D – Preclinical
sotorasib + DT2216
Sensitive
:
D
sotorasib + DT2216
Sensitive: D – Preclinical
sotorasib + DT2216
Sensitive
:
D
JAK2 mutation
Acute Myelogenous Leukemia
JAK2 mutation
Acute Myelogenous Leukemia
DT2216
Sensitive: D – Preclinical
DT2216
Sensitive
:
D
DT2216
Sensitive: D – Preclinical
DT2216
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.